Search by Drug Name or NDC
NDC 69367-0253-30 TRIPROLIDINE HYDROCHLORIDE 0.938 mg/mL Details
TRIPROLIDINE HYDROCHLORIDE 0.938 mg/mL
TRIPROLIDINE HYDROCHLORIDE is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by Westminster Pharmaceuticals, LLC. The primary component is TRIPROLIDINE HYDROCHLORIDE.
Product Information
| NDC | 69367-0253 |
|---|---|
| Product ID | 69367-253_63d97fa4-9b2d-4eef-8865-0cc4af5bc9e8 |
| Associated GPIs | 41100040100940 |
| GCN Sequence Number | 072165 |
| GCN Sequence Number Description | triprolidine HCl DROPS 0.938MG/ML ORAL |
| HIC3 | Z2P |
| HIC3 Description | ANTIHISTAMINES - 1ST GENERATION |
| GCN | 36284 |
| HICL Sequence Number | 004508 |
| HICL Sequence Number Description | TRIPROLIDINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | TRIPROLIDINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | TRIPROLIDINE HYDROCHLORIDE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SYRUP |
| Route | ORAL |
| Active Ingredient Strength | 0.938 |
| Active Ingredient Units | mg/mL |
| Substance Name | TRIPROLIDINE HYDROCHLORIDE |
| Labeler Name | Westminster Pharmaceuticals, LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M012 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69367-0253-30 (69367025330)
| NDC Package Code | 69367-253-30 |
|---|---|
| Billing NDC | 69367025330 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (69367-253-30) / 30 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2020-03-09 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.54847 |
| Pricing Unit | ML |
| Effective Date | 2023-10-18 |
| NDC Description | TRIPROLIDINE 0.938 MG/ML DROPS |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis